Clinical trials
Phase 3 trials in Luxembourg
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 4 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Sanofi | 3 |
| Institut National de la Santé Et de la Recherche Médicale, France | 2 |
| Pfizer | 2 |
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 2 |
| Amgen | 1 |
| Ariad Pharmaceuticals | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 3 |
| Arthritis, Rheumatoid | 2 |
| Breast Neoplasms | 2 |
| Infections | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lung Neoplasms | 2 |
| Neoplasms | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Adenocarcinoma | 1 |
| Anemia | 1 |
Trials
Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.